Events

Events: Excited to attend PharmaGoraPlus in Paris this weekend!

Published on 10 March 2026

This is a key gathering for policymakers, industry leaders, and innovators to discuss digital health, patient engagement, market access, and the future of pharmacy.

I’ll be attending on behalf of Lyfegen, where I’ll also be presenting our work and solutions supporting value-based healthcare and smarter market access.

As a health policy consultant & advisor, it’s a great opportunity to stay on top of regulatory trends, explore innovative approaches, and connect with stakeholders across the healthcare ecosystem.

🤝 If you’re attending or are in Paris as well, let’s connect!

Natacha Fovel, Satellite Consultancy

#Pharmagora2026 #HealthPolicy #DigitalHealth #MarketAccess #Networking #Paris

Share this article:

Steering towards efficiency in the belgian healthcare system 🇧🇪

Published on 25th February 2026

Excellent exchange today at the cabinet of the Vice-Prime Minister and Minister of Economy, David Clarinval with Gaetano Bonifacio, PhD, MBA, Lyfegen's President, Head of Sales.

The stakes are high: as the RIZIV-INAMI must make significant savings within its pharmaceutical budget, optimizing the management of rebate contracts has become a strategic priority. 💡

Our platform will allow authorities to secure back their entire drug budgets and go even further by systematically recovering missed rebates. This represents an immediate and concrete financial optimization lever for the INAMI/RIZIV.

A big thank you to the cabinet members for the quality of our discussions. We look forward to supporting the Belgian authorities in this transformation. 🤝

As we say in Belgium: We zullen zien, ce qu’on va voir ! 😉 (We will see what we will see!)

#HealthTech #DigitalHealth #BelgianGovernment

#Lyfegen #INAMI #PublicHealth #Pharma #Innovation

Natacha Fovel, Satellite Consultancy

Share this article:

News from Davos, Day 2: High-Stakes Meetings and a world standing still

Published on 21st January 2026

My second and final day in Davos was every bit as impactful as the first. As I head home on the train, I’m exhausted but thrilled by the momentum we’ve built for Lyfegen.

The Highlights:

🇧🇪 Government Momentum: I had the honor of meeting the Vice-Prime Minister of Belgium and Minister of Economy, David Clarinval. He showed great interest in how Lyfegen's AI rebate management solutions can support the Belgian healthcare landscape. He immediately introduced me to his Chief of Cabinet to arrange a follow-up in Belgium! (I think my parents will be happy; it means another business trip home!)

🤝 Strengthening Ties: I crossed paths again with Prime Minister Bart De Wever at the Belgium House. This time, I can officially say he knows me! Despite being on his way to meet Donald Trump, he took a moment for another (better!) photo and shared his interest towards Lyfegen again. Fingers crossed!🤞

🇺🇸A Moment of Silence: I witnessed Donald Trump Jr.'s arrival at the Davos Congress Center. I have never seen security like it, the world literally stood still for 10 minutes. No movement, no noise, just helicopters and cleared roads. Snipers looking at you from the top of the building. A surreal experience.

🇺🇦 Resilience & Courage: At the Ukraine House, I was honored to meet members of the Ukrainian Army and congratulate them on their incredible bravery. Respect!

🇧🇪 My Biggest Takeaway: I am incredibly proud of Belgium’s massive presence in Davos! 🇧🇪 Walking down the "Promenade," you are surrounded by American tech giants and global powerhouses. And right in the middle of it all... The Belgium House. With a strong delegation (including the King and Queen!), they stood out for their unique approach: they were the only ones serving Belgian beers to the panelists! 🍺Atmosphere was nice and welcoming. It just felt like home. Cheers to that Belgian spirit!

♥️I’m leaving Davos with a full heart and a long list of follow-ups. Everyone I met seemed to embrace the need for Lyfegen’s innovative tools.

🚗Now, I can’t wait to get home and tell my kids all about this adventure! ✨

Natacha Fovel, Satellite Consultancy 🚄💨

Share this article:

News from Davos: Day 1: Moutains, Magic & High-level Impact

Published on 20th January 2026

Greetings from the #WEF26 World Economic Forum! My first day in Davos has been a whirlwind of power, innovation, and resilience.

It truly is the place to be, though the intensity is real. Between the 5-hour daily commute and the sheer volume of connections, a good night’s sleep is hard to come by - the brain simply doesn't want to switch off! 🧠🚀

Highlights from an incredible Day 1:

🇧🇪 Government Impact: I had the honor of meeting the Belgian Prime Minister, Bart de Wever at the Belgium House. He showed a genuine interest in how

hashtag

#Lyfegen’s innovative rebate management solution can benefit Belgian patients while optimizing the national health security budget. A very promising start!

💊 Industry Leadership: It was a pleasure crossing paths with Stefaan Fiers, Head of External Affairs at Roche Pharma (Belgium). Stefaan is an inspiring leader and always open to discussing healthcare innovation. It truly is a small world here!

🇨🇦 Global Perspectives: Catching Justin Trudeau and Katy Perry was a fascinating highlight, specifically hearing the ex Prime Minister discuss soft power governance and Canada’s distinct sovereign identity.

🤝 Teamwork: It was fantastic to spend the day navigating the Davos landscape with Michel Mohler, Founder and CFO of Lyfegen. There is nothing like experiencing the energy of this forum together as we drive our mission forward.

I’m heading back in for another day full of mystery and encounters. Let the magic begin! 🪄

Natacha Fovel, Satellite Consultancy

Share this article:

News: Heading to Davos for the World Economic Forum

Published on 16th January 2026

👋 Dear all,

✨ I am very pleased to share that next week I will be heading to Davos, Switzerland 🇨🇭, to attend the World Economic Forum (WEF) Annual Meeting. I will be there with Michel Mohler, Founder and CFO of Lyfegen.

🌐 For those who may not be familiar, the WEF is an independent international organization that brings together global leaders from government, business, academia, and civil society to shape global, regional, and industry agendas. Its Annual Meeting in Davos is one of the most influential global gatherings, with more than 70 heads of state and government expected to attend this year, alongside CEOs, policymakers, and thought leaders from across sectors.

❄️ What is truly awesome about this event is, without a doubt, its location. If you have never been before, Davos is a beautiful Swiss village nestled in the heart of the Graubünden Alps, part of the Swiss Alps 🏔️. 📍 Sitting at an altitude of 1,560 meters (5,120 feet) above sea level, it is one of the highest towns in Europe. 🌍 Bringing together so many VIPs from all over the world makes it even more exceptional. I will be happy to share how it feels to be there during the event.

💊🏛️ The WEF is therefore, without a doubt, a must-attend event for anyone, like me, working at the intersection of the pharmaceutical industry, patient organisations, and public authorities. 🗣️ This will be the time to ensure that every single voice is heard, and that every new innovation is known and embraced.

📅 During the week, we will mainly be attending events organized by the @House of Switzerland, House of Belgium, USA House, and AI House, as well as as many sessions as possible related to health, artificial intelligence 🤖, and market access.

🤝 If you are also attending Davos, I would be delighted to connect. 💬 And if you are interested in learning more about Lyfegen’s solutions and how they can accelerate drug access while simultaneously optimizing healthcare budgets, please don’t hesitate to reach out!

Natacha Fovel, Satellite Consultancy

Share this article:

Innovation Meets Public Policy: Lyfegen at the French Senate 🇫🇷

Published on 7th January 2026

🌲As the holiday season draws to a close, the work to transform healthcare efficiency is already in full swing! 💪

Alongside Lyfegen’s CEO Girisha Fernando, we are continuing our series of meetings with key public authorities in France. Our goal is to introduce them to the innovative solutions our Swiss health-tech has developed to optimize pharmaceutical spending. 💊

Today, we had the honor of meeting with three prominent Members of the French Senate:

📍Laurent Somon, Vice-President of the LR Group.

📍Corinne Imbert, Secretary of the Social Affairs Committee.

📍Milon Alain, outgoing President of the Social Affairs Committee

As they are directly involved in the body responsible for overseeing the Social Security budget and healthcare spending in France 🏛️, we were thrilled by their positive reception; the consensus was clear: it is a strategic necessity for health authorities to explore Lyfegen’s solution.

Our initial step is simple: we audit and recover missed rebates that have gone uncollected. There is no upfront cost for the healthcare system, as audit and recovery are done through a performance-based model where Lyfegen only takes a percentage of the recovered funds 💰, a feature that is particularly relevant for governments navigating budget restrictions.

It is now time to head back to Switzerland through a snowy France☃️. We look forward to following up with the key stakeholders we’ve engaged with this week and are excited about what will come next.

This is just the beginning, and a fantastic start to 2026! 🚀

Share this article:

Advancing Access to Innovation: High-Level Policy Dialogues in France and Belgium

Published on 19th December 2025

It has been a high-level, intensive week for Lyfegen in France and Belgium! 🇫🇷 🇧🇪

Alongside Girisha Fernando (CEO of Lyfegen) and Donal Ryan (Vice President of Sales), we had the honor of meeting with key members of ministerial cabinets to discuss the future of financing therapeutic innovation:

📍 In Brussels: At the Deputy Prime Minister’s Office, to build bridges between technology and patient access.

📍 In Paris: At the Ministry of Economy and Finance (Bercy), to discuss the efficiency of healthcare spending.

✈️In a global context where pressure on drug pricing is intensifying (notably with recent US policy shifts), our discussions confirmed a shared priority: securing access to innovative treatments through effective, data-driven reimbursement models.

👏Now more than ever, Lyfegen stands as a trusted partner for governments, transforming complexity into opportunity thanks to AI-driven drug contracting and rebate management solutions.

♥️A huge thank you to everyone who supported the preparation for these meetings (Nico Julian Mros, Perrine Vallet and Ana Martinez) it was truly a team effort! A special thanks to my partner as well…Laurent Nave who has been so patient and supportive as I dedicate 150% to my new role and company Satellite Consultancy.

As you can see it has been an incredibly intense period, and now it is time to disconnect, spend some meaningful time with family and friends. I look forward to recharging and returning in the New Year, ready to tackle new exciting challenges and opportunities 🫀to advance health for patients around the world! 🔋✨

Wishing everyone happy end of year celebrations 🎉🎇🥳✴️

Share this article:

Update from the European Health Summit in Brussels

Published on 4th December 2025

I’m delighted to share that I attended

hashtag

#EHS2025 in Brussels this week, proudly representing Lyfegen together with my colleagues Donal Ryan and Nico Julian Mros. It has been an incredibly insightful and fruitful week! ✨🤝

🔑 Key Messages Echoed Across the Panels

➡️ Healthcare systems are under immense pressure, especially due to budget constraints. Several smaller countries even highlighted that limited resources make it difficult to invest in new innovative therapies.

➡️ Industry leaders expressed concerns about Europe’s slow and complex regulatory landscape, wishing they could bring innovation faster to patients. 🚀💊

💡 How Lyfegen Can Help

Hearing these challenges, I couldn’t help but ask many stakeholders the same question:

➡️ Did you know that Lyfegen has already developed AI-driven solutions that directly address these issues?

With Lyfegen’s innovative drug access, pricing, and rebate management platform, you can:

✅ Negotiate faster — whether you’re a pharma company or a payer

✅ Optimize health budgets significantly

✅ Accelerate patient access to innovative treatments

This message resonated strongly throughout

hashtag

#EHS2025, and I’m thrilled to share that many key healthcare leaders showed genuine interest and engaged in meaningful discussions with us. 💬✨

🤝 Engaging With European Member States

As you can see from the pictures, our team had the pleasure of exchanging with:

➡️ Spyridon-Adonis Georgiadis, Minister of Health, Greece

➡️ Monica Garcia Gomez, Minister of Health, Spain

➡️ Jo Etienne Abela, Minister of Health and Active Ageing, Malta

➡️ Daniel Naumovas, Vice-Minister of Health, Lithuania

➡️ Rui Santos Ivo, President of INFARMED, Portugal

📌Strengthening Visibility With EU Authorities

We also highlighted Lyfegen’s value proposition to key EU decision-makers, including:

✴️Sandra Gallina, Director General, DG SANTE, European Commission

✴️Oliver Varhelyi, Commissioner for Health and Animal Welfare, European Commission

✨ It has truly been an energizing and impactful few days in Brussels🙏A huge thank you to everyone who contributed to this inspiring summit! As one key panel speaker powerfully stated during

hashtag

#EHS2025:

➡️ The time is now to make the right decision!

So let’s connect and continue the conversation, together, we can positively impact patients around the globe. 🌍🤝

Share this article:

News: Attending the European Health Summit in Brussels

Published on 28th November 2025

Dear network, 😊🌍

I’m delighted to share that I will be attending the #EuropeanHealthSummit in Brussels next week, organized by the #EuropeanBusinessSummits. 🇪🇺✨

Under the theme “NextGen Simplified: Rethinking Health for Tomorrow,” the 2025 edition of EHS will once again provide a leading platform to advance Europe’s health agenda through high-level dialogue with key cross-sector stakeholders. 💬🤝

Discussions will focus on four strategic pillars:

🚀 Driving innovation and competitiveness to strengthen Europe’s leadership in medical advancements;

🛡️ Boosting preparedness and resilience to build robust, crisis-ready healthcare systems;

💙 Enhancing prevention and access to shift from reactive treatments to proactive, patient-centred care;

🌱 Promoting sustainability and societal impact to ensure equitable and environmentally responsible healthcare models.

The Summit will also feature an impressive lineup of high-profile speakers 🎤🌟, and I look forward to engaging with peers and leaders in the inspiring setting of the Palais d’Egmont, one of the most beautiful historical venues in Brussels. 🏛️✨

I’m excited to represent Lyfegen at this key event and to meet with my new peers Donal Ryan and Nico Julian Mros, so we can explore how Lyfegen's innovative AI-driven solution for drug-pricing contract management can help companies and authorities optimize budget allocation while improving patient access worldwide. 💊🌎

If you will be attending and would like to connect, feel free to reach out! 🤗

Natacha

Check the programme out: https://lnkd.in/eAHnUDSW

Share this article:

Update from the Politico Health Care Summit in Brussels

Published on 21st November 2025

🏛️This week, I attended the Politico Health Care Summit in Brussels, and it felt great to be back in the capital of Europe, my hometown, reconnecting with so many familiar faces 🤝. The discussions were intense and eye-opening, reminding us just how urgent Europe’s situation has become and how many steps we still need to take to stay competitive.

Today, our health systems face mounting pressure:
🌍 climate-driven health threats
⚔️ war at Europe’s doorstep
🌐 geopolitical instability across the Atlantic
📉 rising mental-health issues among children linked to digital overexposure
😴 worsening sleep and burnout among adults

And the challenges don’t stop there: Europe is seeing declining clinical trials, falling investment in healthcare innovation, and long delays in patient access to new medicines.

Expectations are high. Europe is increasingly seen as the actor that must step up, not only for itself, but to safeguard global health at a time when others step back 🌎.

Yet the summit also delivered a welcome dose of optimism ✨.
We do have solutions. Europe has the means, the talent, and the ambition to build a resilient, innovative, patient-centred health system. Germany is showing what’s possible. Prevention works. Incentives work. AI works. But it’s not a black-magic box: we need the right conditions to implement it and fully unlock its potential, just as is already happening in Canada’s healthcare system.

Not everything is as complicated as we think. What we need now is trust, smarter investment, simpler processes, and yes, a bit more funding 💶, because progress comes at a cost and we have seen that the cost of inaction is greater than the cost of action.

Throughout the summit, I engaged with policymakers and industry leaders to demonstrate how Lyfegen’s AI-powered platform can help close the biggest gaps they face:
⚡ accelerating patient access
💸 reducing financial burden for payers
📊 enabling evidence-based decisions with real-world data

I look forward to following up with them, because patients deserve faster access to innovative therapies, and Lyfegen can make a tangible difference today.

⭐A personal highlight was my meeting with Belgium’s Minister of Health, Frank Vandenbroucke. Beyond being incredibly kind; while he was revising his speech, he accepted to have a picture with me and a quick chat 📸. ((A huge thanks to his very kind and talented adviser, Gloria.) Later on, his speech showed a genuine commitment and strong political passion for improving healthcare in Belgium and across Europe.

A challenging moment for Europe, yes. But also a moment full of opportunity, if we choose to act 💡.

#PoliticoHealthCare #Brussels #HealthcareInnovation #MarketAccess #FastAccess #ValueBasedHealthcare #DigitalHealth #AIinHealthcare #HealthData #RealWorldEvidence #HealthPolicy #Networking #EuropeanHealth #HealthTech

Share this article:

News: Attending the Politico Health Care Summit in Brussels

Published on 13th November 2025

Dear network,

I’m excited to share that I will be attending the POLITICO Health Care Summit next week in Brussels!🏛️💡 I’m looking forward to engaging in insightful discussions on the future of healthcare, 🤝connecting with industry leaders and policy makers and exploring innovative approaches to health policy.

If you’ll be attending as well, please let me know, I’d love to connect or reconnect ;) 😉✨

#HealthPolicy #HealthcareInnovation #PoliticoHealthCareSummit

#Networking #Brussels #Sustainability #AI #GlobalHealth

Share this article:

Update from the Unite Summit for Women and cardiovascular Health in Dublin

Published on 2nd November 2025

What an inspiring and action-packed event bringing together brilliant minds and changemakers! Here are my key takeaways 👇

❗ Awareness gap:

Nearly 50% of women are unaware that cardiovascular disease (CVD) symptoms differ for women, and most don’t know what those symptoms are such as nausea, dizziness, or jaw pain.

💔 The #1 killer:

1 in 3 women worldwide will die from CVD, the leading cause of death for women. Yet many believe breast cancer is their biggest risk, while it actually ranks fourth.

😔 Bias in diagnosis:

When men and women arrive at the emergency room with chest pain, men are far more likely to be examined for heart disease, while women are often dismissed or told they’re experiencing anxiety or menopause-related symptoms.

👩‍👧‍👦 Clinical trials & drug testing:

Women are underrepresented in clinical trials, partly because work, family, and caregiving leave them little time to participate. As a result, many approved drugs haven’t been properly tested on women yet are still prescribed to them. Since women metabolize medications differently, what’s safe for men can be harmful for women.

🔍 Example: certain oral hormone replacement therapies (HRT) can increase CVD risk in women with pre-existing heart conditions.

🔥 The menopause factor:

From the onset of menopause women face a 50% higher risk of developing CVD. The decline in estrogen removes a vital layer of protection, and this phase represents roughly 30% of a woman’s life.

🚬 Smoking hits women harder:

Because women’s coronary arteries are smaller, smoking just 3 cigarettes a day can be as damaging as a man smoking an entire pack.

📚 Medical education still lags behind:

Most medical schools offer only one class on women’s health, and cardiovascular disease is rarely covered. As a result, many healthcare professionals even cardiologists lack the training to recognize and address women’s specific symptoms, leading to frequent misdiagnoses.

🌍 Cultural and religious barriers: In some culture;

-Women are discouraged from seeking care if they are ill, as their families may view it as a burden.

-Being overweight is associated with fertility and respect

-Religious beliefs discourage seeking medical help, viewing illness as “God’s will

💡 In the 21st century, when women represent 51% of the global population, this is simply unacceptable. Women deserve to be seen, heard, studied, diagnosed, and treated effectively.

🙏 A huge thank you to all experts and Global Heart Hub for making this summit so special and also to MEP Maria Walsh, who joined and who is working tirelessly in Brussels to include as many recommendations as possible in the upcoming 💙 EU Cardiovascular Plan.

With Anna Dé our next step is to turn these insights into concrete actions to drive policy change and a real shift in mindset.

#WomensHealth #CardiovascularDisease #GenderEquality #GHHUnite

#PolicyChange #WomensVoicesMatter

Share this article:

Bernoullistrasse 20

4056 Basel, Switzerland

Let's connect !

Page updated

Google Sites

Report abuse